Touro College of Pharmacy is celebrating completion of a new, multi-disciplinary research laboratory by hosting a symposium that will bring together renowned scientists, academicians, and industrial leaders in pharmaceutics and biotechnology. Titled “Translational Medicine: Scientific Initiatives Designed to Deliver Future Healthcare Benefits,” the symposium will take place on Thursday, November 15 at the Touro College of Pharmacy, located at 231 W. 124th Street in Harlem, 12:30—6:30 p.m.
Translational medicine is a medical practice that uses scientific research to optimize patient care, turning appropriate biological discoveries into drugs and medical devices that can be used in treatment.
“In hosting this symposium to celebrate our new laboratory, Touro College of Pharmacy is underscoring its commitment to creating a premier academic institution in the pharmacological sciences,” said Zvi G. Loewy, Ph.D., professor and chair of the College’s department of pharmaceutical and biomedical sciences.
After introductory and welcoming remarks from founding dean Dr. Stuart Feldman, four scientists from industry and academia will present on two main areas of interest in translational medicine: oncology and antibiotics. The presentations will be followed by a panel discussion moderated by Dr. Loewy.
The speakers are Dr. Herman Steller, Strang Professor and Investigator, Howard Hughes Medical Institute of The Rockefeller University, who will discuss “Targeting IAPs for Cancer Therapy”; Dr. Allan R. Goldberg, CEO, Avacyn Pharmaceuticals, who will speak on “Developing the Next Generation of Anti-Bacterial Drugs to Overcome Induction to Drug Resistance: A Collaboration Between Academia and Industry”; Dr. Mitchell S. Cairo, chief, pediatric hematology, oncology, and stem cell transplantation and professor of pediatrics, medicine, pathology, microbiology and immunology, and cell biology and anatomy at New York Medical College, who will address “Treatment of Pediatric Burkitt Lymphoma: Bedside to Bench and Back to Bedside”; and Dr. Cristina Giachetti, senior vice president, research and development, Hologic/Gen-Probe, who will speak about “HPV Oncogenic mRNA Detection in Cervical Cancer Screening.”